nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GRIA3—Topiramate—migraine	0.429	1	CbGbCtD
Lithium—schizophrenia—Valproic Acid—migraine	0.417	1	CpDpCtD
Lithium—GRIA3—nerve—migraine	0.00563	0.14	CbGeAlD
Lithium—GSK3B—nerve—migraine	0.00487	0.121	CbGeAlD
Lithium—IMPA1—cardiovascular system—migraine	0.00232	0.0577	CbGeAlD
Lithium—GSK3A—trigeminal ganglion—migraine	0.00205	0.0511	CbGeAlD
Lithium—GSK3B—cardiovascular system—migraine	0.00171	0.0425	CbGeAlD
Lithium—IMPA1—head—migraine	0.00157	0.0391	CbGeAlD
Lithium—IMPA1—nervous system—migraine	0.00149	0.037	CbGeAlD
Lithium—GSK3A—cardiovascular system—migraine	0.00148	0.0369	CbGeAlD
Lithium—IMPA1—central nervous system—migraine	0.00143	0.0356	CbGeAlD
Lithium—GRIA3—head—migraine	0.00133	0.0332	CbGeAlD
Lithium—GRIA3—nervous system—migraine	0.00127	0.0315	CbGeAlD
Lithium—GSK3B—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MEF2D—migraine	0.00126	0.0534	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—KCNK18—migraine	0.00122	0.0516	CbGpPWpGaD
Lithium—GRIA3—central nervous system—migraine	0.00122	0.0303	CbGeAlD
Lithium—GRIA3—cerebellum—migraine	0.00119	0.0296	CbGeAlD
Lithium—GSK3B—head—migraine	0.00116	0.0288	CbGeAlD
Lithium—IMPA1—brain—migraine	0.00114	0.0283	CbGeAlD
Lithium—GSK3B—nervous system—migraine	0.0011	0.0273	CbGeAlD
Lithium—GSK3A—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.00107	0.0452	CbGpPWpGaD
Lithium—GSK3B—central nervous system—migraine	0.00106	0.0262	CbGeAlD
Lithium—GSK3B—cerebellum—migraine	0.00103	0.0257	CbGeAlD
Lithium—GSK3A—head—migraine	0.001	0.025	CbGeAlD
Lithium—GRIA3—brain—migraine	0.000967	0.0241	CbGeAlD
Lithium—GSK3A—nervous system—migraine	0.000953	0.0237	CbGeAlD
Lithium—GSK3A—central nervous system—migraine	0.000917	0.0228	CbGeAlD
Lithium—GSK3A—cerebellum—migraine	0.000897	0.0223	CbGeAlD
Lithium—IMPA2—brain—migraine	0.000854	0.0212	CbGeAlD
Lithium—GSK3B—brain—migraine	0.000838	0.0208	CbGeAlD
Lithium—GSK3B—B Cell Receptor Signaling Pathway—MEF2D—migraine	0.000791	0.0334	CbGpPWpGaD
Lithium—GRIA3—Transmission across Chemical Synapses—CACNA1A—migraine	0.000779	0.0329	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000756	0.0319	CbGpPWpGaD
Lithium—GSK3A—brain—migraine	0.000728	0.0181	CbGeAlD
Lithium—GSK3B—Alzheimers Disease—LRP1—migraine	0.00068	0.0287	CbGpPWpGaD
Lithium—GSK3B—Notch Signaling Pathway—NOTCH4—migraine	0.000642	0.0271	CbGpPWpGaD
Lithium—GRIA3—Neuronal System—CACNA1A—migraine	0.000597	0.0252	CbGpPWpGaD
Lithium—GSK3A—FOXM1 transcription factor network—ESR1—migraine	0.000572	0.0242	CbGpPWpGaD
Lithium—GSK3B—Notch Signaling Pathway—NOTCH3—migraine	0.000546	0.0231	CbGpPWpGaD
Lithium—IMPA1—Integrated Breast Cancer Pathway—ESR1—migraine	0.000546	0.0231	CbGpPWpGaD
Lithium—GSK3A—IL-5 Signaling Pathway—FOS—migraine	0.000536	0.0226	CbGpPWpGaD
Lithium—GSK3A—FOXM1 transcription factor network—FOS—migraine	0.000515	0.0218	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—NOTCH4—migraine	0.000429	0.0181	CbGpPWpGaD
Lithium—GSK3B—LKB1 signaling events—ESR1—migraine	0.000415	0.0175	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—BDNF—migraine	0.000397	0.0168	CbGpPWpGaD
Lithium—GSK3B—IL-5 Signaling Pathway—FOS—migraine	0.000396	0.0167	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—SCN1A—migraine	0.000388	0.0164	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—PGR—migraine	0.000383	0.0162	CbGpPWpGaD
Lithium—GSK3B—Neural Crest Differentiation—NOTCH3—migraine	0.000365	0.0154	CbGpPWpGaD
Lithium—GSK3A—Leptin signaling pathway—ESR1—migraine	0.00036	0.0152	CbGpPWpGaD
Lithium—GSK3B—Presenilin action in Notch and Wnt signaling—FOS—migraine	0.000354	0.015	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—SCN2A—migraine	0.00033	0.0139	CbGpPWpGaD
Lithium—IMPA2—Metabolism—CACNA1A—migraine	0.000321	0.0136	CbGpPWpGaD
Lithium—IMPA1—Metabolism—CACNA1A—migraine	0.000286	0.0121	CbGpPWpGaD
Lithium—GSK3A—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000285	0.012	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—PGR—migraine	0.000283	0.0119	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—SCN1A—migraine	0.000277	0.0117	CbGpPWpGaD
Lithium—GSK3B—LPA receptor mediated events—FOS—migraine	0.000272	0.0115	CbGpPWpGaD
Lithium—GRIA3—BDNF signaling pathway—FOS—migraine	0.000268	0.0113	CbGpPWpGaD
Lithium—Salivary hypersecretion—Topiramate—migraine	0.000267	0.00295	CcSEcCtD
Lithium—GSK3B—Leptin signaling pathway—ESR1—migraine	0.000266	0.0112	CbGpPWpGaD
Lithium—Depressed level of consciousness—Topiramate—migraine	0.000265	0.00293	CcSEcCtD
Lithium—Urinary incontinence—Topiramate—migraine	0.000265	0.00293	CcSEcCtD
Lithium—Oedema—Amitriptyline—migraine	0.000264	0.00292	CcSEcCtD
Lithium—Dry skin—Valproic Acid—migraine	0.000262	0.0029	CcSEcCtD
Lithium—Shock—Amitriptyline—migraine	0.00026	0.00288	CcSEcCtD
Lithium—Tinnitus—Verapamil—migraine	0.00026	0.00287	CcSEcCtD
Lithium—Anorexia—Amitriptyline—migraine	0.000252	0.00279	CcSEcCtD
Lithium—Muscular weakness—Valproic Acid—migraine	0.000252	0.00279	CcSEcCtD
Lithium—Thirst—Gabapentin—migraine	0.000249	0.00275	CcSEcCtD
Lithium—Urine output increased—Topiramate—migraine	0.000248	0.00274	CcSEcCtD
Lithium—Hypotension—Amitriptyline—migraine	0.000247	0.00273	CcSEcCtD
Lithium—Alopecia—Verapamil—migraine	0.000246	0.00272	CcSEcCtD
Lithium—Agitation—Propranolol—migraine	0.000242	0.00268	CcSEcCtD
Lithium—Lethargy—Gabapentin—migraine	0.000242	0.00267	CcSEcCtD
Lithium—Hypertonia—Topiramate—migraine	0.000241	0.00266	CcSEcCtD
Lithium—Vertigo—Propranolol—migraine	0.000237	0.00262	CcSEcCtD
Lithium—GSK3B—Developmental Biology—SCN2A—migraine	0.000235	0.00994	CbGpPWpGaD
Lithium—Somnolence—Amitriptyline—migraine	0.000235	0.0026	CcSEcCtD
Lithium—Dyspepsia—Amitriptyline—migraine	0.000233	0.00257	CcSEcCtD
Lithium—Decreased appetite—Amitriptyline—migraine	0.00023	0.00254	CcSEcCtD
Lithium—Vision blurred—Verapamil—migraine	0.000229	0.00253	CcSEcCtD
Lithium—Convulsion—Propranolol—migraine	0.000229	0.00253	CcSEcCtD
Lithium—Fatigue—Amitriptyline—migraine	0.000228	0.00252	CcSEcCtD
Lithium—Tremor—Verapamil—migraine	0.000227	0.00251	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000227	0.00959	CbGpPWpGaD
Lithium—Polyuria—Topiramate—migraine	0.000227	0.00251	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—NPS—migraine	0.000226	0.00956	CbGpPWpGaD
Lithium—Weight increased—Valproic Acid—migraine	0.000225	0.00248	CcSEcCtD
Lithium—Weight decreased—Valproic Acid—migraine	0.000223	0.00247	CcSEcCtD
Lithium—Agitation—Verapamil—migraine	0.000223	0.00247	CcSEcCtD
Lithium—GSK3B—Glucocorticoid receptor regulatory network—FOS—migraine	0.000223	0.00942	CbGpPWpGaD
Lithium—Ataxia—Gabapentin—migraine	0.000223	0.00246	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—SLC6A4—migraine	0.000222	0.00937	CbGpPWpGaD
Lithium—Angioedema—Verapamil—migraine	0.000222	0.00245	CcSEcCtD
Lithium—Dehydration—Gabapentin—migraine	0.00022	0.00244	CcSEcCtD
Lithium—Drowsiness—Valproic Acid—migraine	0.00022	0.00243	CcSEcCtD
Lithium—Vertigo—Verapamil—migraine	0.000218	0.00241	CcSEcCtD
Lithium—Feeling abnormal—Amitriptyline—migraine	0.000218	0.00241	CcSEcCtD
Lithium—Syncope—Verapamil—migraine	0.000218	0.00241	CcSEcCtD
Lithium—Dry skin—Gabapentin—migraine	0.000217	0.0024	CcSEcCtD
Lithium—GSK3B—Developmental Biology—MEF2D—migraine	0.000215	0.00909	CbGpPWpGaD
Lithium—Loss of consciousness—Verapamil—migraine	0.000213	0.00236	CcSEcCtD
Lithium—Convulsion—Verapamil—migraine	0.00021	0.00232	CcSEcCtD
Lithium—GSK3B—BDNF signaling pathway—BDNF—migraine	0.00021	0.00888	CbGpPWpGaD
Lithium—Gastritis—Gabapentin—migraine	0.00021	0.00232	CcSEcCtD
Lithium—Thirst—Topiramate—migraine	0.000209	0.00231	CcSEcCtD
Lithium—Body temperature increased—Amitriptyline—migraine	0.000209	0.00231	CcSEcCtD
Lithium—Muscular weakness—Gabapentin—migraine	0.000209	0.00231	CcSEcCtD
Lithium—Arthralgia—Verapamil—migraine	0.000207	0.00228	CcSEcCtD
Lithium—GSK3A—Integrated Breast Cancer Pathway—ESR1—migraine	0.000205	0.00868	CbGpPWpGaD
Lithium—GSK3B—TWEAK Signaling Pathway—TNF—migraine	0.000205	0.00865	CbGpPWpGaD
Lithium—GSK3A—Signaling by ERBB4—ESR1—migraine	0.000204	0.00863	CbGpPWpGaD
Lithium—Discomfort—Verapamil—migraine	0.000204	0.00226	CcSEcCtD
Lithium—GSK3B—Corticotropin-releasing hormone—FOS—migraine	0.000203	0.00859	CbGpPWpGaD
Lithium—Lethargy—Topiramate—migraine	0.000203	0.00225	CcSEcCtD
Lithium—Erectile dysfunction—Timolol—migraine	0.000202	0.00224	CcSEcCtD
Lithium—Dry mouth—Verapamil—migraine	0.000202	0.00223	CcSEcCtD
Lithium—Bradycardia—Valproic Acid—migraine	0.000201	0.00222	CcSEcCtD
Lithium—Confusional state—Verapamil—migraine	0.0002	0.00221	CcSEcCtD
Lithium—Weight decreased—Timolol—migraine	0.000199	0.0022	CcSEcCtD
Lithium—Hyperglycaemia—Timolol—migraine	0.000198	0.00219	CcSEcCtD
Lithium—Oedema—Verapamil—migraine	0.000198	0.00219	CcSEcCtD
Lithium—Hallucination—Valproic Acid—migraine	0.000197	0.00217	CcSEcCtD
Lithium—Shock—Verapamil—migraine	0.000195	0.00215	CcSEcCtD
Lithium—GSK3B—Circadian rythm related genes—HTR7—migraine	0.000194	0.00821	CbGpPWpGaD
Lithium—Somnolence—Propranolol—migraine	0.000191	0.00212	CcSEcCtD
Lithium—Asthenia—Amitriptyline—migraine	0.00019	0.0021	CcSEcCtD
Lithium—Dyspepsia—Propranolol—migraine	0.00019	0.0021	CcSEcCtD
Lithium—Erectile dysfunction—Gabapentin—migraine	0.000189	0.00208	CcSEcCtD
Lithium—Ataxia—Topiramate—migraine	0.000187	0.00207	CcSEcCtD
Lithium—Decreased appetite—Propranolol—migraine	0.000187	0.00207	CcSEcCtD
Lithium—Weight increased—Gabapentin—migraine	0.000186	0.00206	CcSEcCtD
Lithium—Fatigue—Propranolol—migraine	0.000186	0.00205	CcSEcCtD
Lithium—Dehydration—Topiramate—migraine	0.000185	0.00205	CcSEcCtD
Lithium—Weight decreased—Gabapentin—migraine	0.000185	0.00205	CcSEcCtD
Lithium—Hypotension—Verapamil—migraine	0.000185	0.00205	CcSEcCtD
Lithium—Hyperglycaemia—Gabapentin—migraine	0.000185	0.00204	CcSEcCtD
Lithium—Tinnitus—Valproic Acid—migraine	0.000184	0.00204	CcSEcCtD
Lithium—Drowsiness—Gabapentin—migraine	0.000183	0.00202	CcSEcCtD
Lithium—Diarrhoea—Amitriptyline—migraine	0.000181	0.002	CcSEcCtD
Lithium—Musculoskeletal discomfort—Verapamil—migraine	0.00018	0.00199	CcSEcCtD
Lithium—Bradycardia—Timolol—migraine	0.000179	0.00198	CcSEcCtD
Lithium—GSK3A—Insulin Signaling—FOS—migraine	0.000177	0.00747	CbGpPWpGaD
Lithium—Arrhythmia—Valproic Acid—migraine	0.000177	0.00195	CcSEcCtD
Lithium—Gastritis—Topiramate—migraine	0.000176	0.00195	CcSEcCtD
Lithium—Somnolence—Verapamil—migraine	0.000176	0.00195	CcSEcCtD
Lithium—Gastrointestinal pain—Propranolol—migraine	0.000176	0.00195	CcSEcCtD
Lithium—Muscular weakness—Topiramate—migraine	0.000176	0.00194	CcSEcCtD
Lithium—Hallucination—Timolol—migraine	0.000175	0.00194	CcSEcCtD
Lithium—Dizziness—Amitriptyline—migraine	0.000175	0.00193	CcSEcCtD
Lithium—Alopecia—Valproic Acid—migraine	0.000175	0.00193	CcSEcCtD
Lithium—Dyspepsia—Verapamil—migraine	0.000174	0.00193	CcSEcCtD
Lithium—Fatigue—Verapamil—migraine	0.000171	0.00189	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.00017	0.00719	CbGpPWpGaD
Lithium—Abdominal pain—Propranolol—migraine	0.00017	0.00188	CcSEcCtD
Lithium—Body temperature increased—Propranolol—migraine	0.00017	0.00188	CcSEcCtD
Lithium—Flatulence—Valproic Acid—migraine	0.00017	0.00187	CcSEcCtD
Lithium—Dysgeusia—Valproic Acid—migraine	0.000168	0.00186	CcSEcCtD
Lithium—Vomiting—Amitriptyline—migraine	0.000168	0.00186	CcSEcCtD
Lithium—Bradycardia—Gabapentin—migraine	0.000167	0.00184	CcSEcCtD
Lithium—Rash—Amitriptyline—migraine	0.000167	0.00184	CcSEcCtD
Lithium—Dermatitis—Amitriptyline—migraine	0.000167	0.00184	CcSEcCtD
Lithium—Headache—Amitriptyline—migraine	0.000166	0.00183	CcSEcCtD
Lithium—GSK3B—Cardiac Hypertrophic Response—TNF—migraine	0.000165	0.00697	CbGpPWpGaD
Lithium—Tinnitus—Timolol—migraine	0.000164	0.00181	CcSEcCtD
Lithium—Feeling abnormal—Verapamil—migraine	0.000163	0.0018	CcSEcCtD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000163	0.00689	CbGpPWpGaD
Lithium—Hallucination—Gabapentin—migraine	0.000163	0.0018	CcSEcCtD
Lithium—Vision blurred—Valproic Acid—migraine	0.000162	0.00179	CcSEcCtD
Lithium—Tremor—Valproic Acid—migraine	0.000161	0.00178	CcSEcCtD
Lithium—Erectile dysfunction—Topiramate—migraine	0.000159	0.00175	CcSEcCtD
Lithium—Agitation—Valproic Acid—migraine	0.000158	0.00175	CcSEcCtD
Lithium—Angioedema—Valproic Acid—migraine	0.000157	0.00174	CcSEcCtD
Lithium—Arrhythmia—Timolol—migraine	0.000157	0.00174	CcSEcCtD
Lithium—Nausea—Amitriptyline—migraine	0.000157	0.00174	CcSEcCtD
Lithium—Weight increased—Topiramate—migraine	0.000157	0.00173	CcSEcCtD
Lithium—Weight decreased—Topiramate—migraine	0.000156	0.00172	CcSEcCtD
Lithium—Alopecia—Timolol—migraine	0.000155	0.00172	CcSEcCtD
Lithium—Hyperglycaemia—Topiramate—migraine	0.000155	0.00172	CcSEcCtD
Lithium—Vertigo—Valproic Acid—migraine	0.000155	0.00171	CcSEcCtD
Lithium—Asthenia—Propranolol—migraine	0.000154	0.00171	CcSEcCtD
Lithium—Tinnitus—Gabapentin—migraine	0.000153	0.00169	CcSEcCtD
Lithium—GSK3B—Signaling by ERBB4—ESR1—migraine	0.000151	0.00638	CbGpPWpGaD
Lithium—Dysgeusia—Timolol—migraine	0.00015	0.00166	CcSEcCtD
Lithium—Diarrhoea—Propranolol—migraine	0.000147	0.00163	CcSEcCtD
Lithium—Arthralgia—Valproic Acid—migraine	0.000146	0.00162	CcSEcCtD
Lithium—Alopecia—Gabapentin—migraine	0.000145	0.0016	CcSEcCtD
Lithium—Discomfort—Valproic Acid—migraine	0.000145	0.0016	CcSEcCtD
Lithium—Vision blurred—Timolol—migraine	0.000144	0.0016	CcSEcCtD
Lithium—Dry mouth—Valproic Acid—migraine	0.000143	0.00158	CcSEcCtD
Lithium—Dizziness—Propranolol—migraine	0.000142	0.00157	CcSEcCtD
Lithium—Asthenia—Verapamil—migraine	0.000142	0.00157	CcSEcCtD
Lithium—GSK3B—BDNF signaling pathway—FOS—migraine	0.000142	0.006	CbGpPWpGaD
Lithium—Confusional state—Valproic Acid—migraine	0.000142	0.00157	CcSEcCtD
Lithium—Flatulence—Gabapentin—migraine	0.000141	0.00155	CcSEcCtD
Lithium—Oedema—Valproic Acid—migraine	0.00014	0.00155	CcSEcCtD
Lithium—Bradycardia—Topiramate—migraine	0.00014	0.00155	CcSEcCtD
Lithium—Angioedema—Timolol—migraine	0.00014	0.00155	CcSEcCtD
Lithium—Dysgeusia—Gabapentin—migraine	0.00014	0.00154	CcSEcCtD
Lithium—Vertigo—Timolol—migraine	0.000138	0.00152	CcSEcCtD
Lithium—Syncope—Timolol—migraine	0.000137	0.00152	CcSEcCtD
Lithium—Hallucination—Topiramate—migraine	0.000137	0.00152	CcSEcCtD
Lithium—Vomiting—Propranolol—migraine	0.000137	0.00151	CcSEcCtD
Lithium—Rash—Propranolol—migraine	0.000136	0.0015	CcSEcCtD
Lithium—Dermatitis—Propranolol—migraine	0.000136	0.0015	CcSEcCtD
Lithium—Diarrhoea—Verapamil—migraine	0.000135	0.0015	CcSEcCtD
Lithium—Loss of consciousness—Timolol—migraine	0.000135	0.00149	CcSEcCtD
Lithium—Vision blurred—Gabapentin—migraine	0.000134	0.00149	CcSEcCtD
Lithium—Anorexia—Valproic Acid—migraine	0.000134	0.00148	CcSEcCtD
Lithium—Tremor—Gabapentin—migraine	0.000134	0.00148	CcSEcCtD
Lithium—Hypotension—Valproic Acid—migraine	0.000131	0.00145	CcSEcCtD
Lithium—Agitation—Gabapentin—migraine	0.000131	0.00145	CcSEcCtD
Lithium—Dizziness—Verapamil—migraine	0.000131	0.00145	CcSEcCtD
Lithium—GSK3B—Insulin Signaling—FOS—migraine	0.000131	0.00552	CbGpPWpGaD
Lithium—Arthralgia—Timolol—migraine	0.00013	0.00144	CcSEcCtD
Lithium—Angioedema—Gabapentin—migraine	0.00013	0.00144	CcSEcCtD
Lithium—Discomfort—Timolol—migraine	0.000129	0.00142	CcSEcCtD
Lithium—Tinnitus—Topiramate—migraine	0.000129	0.00142	CcSEcCtD
Lithium—Vertigo—Gabapentin—migraine	0.000128	0.00142	CcSEcCtD
Lithium—Musculoskeletal discomfort—Valproic Acid—migraine	0.000128	0.00141	CcSEcCtD
Lithium—Syncope—Gabapentin—migraine	0.000128	0.00141	CcSEcCtD
Lithium—Nausea—Propranolol—migraine	0.000128	0.00141	CcSEcCtD
Lithium—Dry mouth—Timolol—migraine	0.000128	0.00141	CcSEcCtD
Lithium—Confusional state—Timolol—migraine	0.000126	0.00139	CcSEcCtD
Lithium—Vomiting—Verapamil—migraine	0.000126	0.00139	CcSEcCtD
Lithium—Loss of consciousness—Gabapentin—migraine	0.000125	0.00139	CcSEcCtD
Lithium—Oedema—Timolol—migraine	0.000125	0.00138	CcSEcCtD
Lithium—Rash—Verapamil—migraine	0.000125	0.00138	CcSEcCtD
Lithium—Somnolence—Valproic Acid—migraine	0.000125	0.00138	CcSEcCtD
Lithium—Dermatitis—Verapamil—migraine	0.000125	0.00138	CcSEcCtD
Lithium—Headache—Verapamil—migraine	0.000124	0.00137	CcSEcCtD
Lithium—Dyspepsia—Valproic Acid—migraine	0.000124	0.00137	CcSEcCtD
Lithium—Convulsion—Gabapentin—migraine	0.000124	0.00137	CcSEcCtD
Lithium—GSK3B—Alzheimers Disease—TNF—migraine	0.000123	0.00522	CbGpPWpGaD
Lithium—Shock—Timolol—migraine	0.000123	0.00136	CcSEcCtD
Lithium—Decreased appetite—Valproic Acid—migraine	0.000122	0.00135	CcSEcCtD
Lithium—Alopecia—Topiramate—migraine	0.000122	0.00135	CcSEcCtD
Lithium—Arthralgia—Gabapentin—migraine	0.000121	0.00134	CcSEcCtD
Lithium—Fatigue—Valproic Acid—migraine	0.000121	0.00134	CcSEcCtD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.00012	0.00509	CbGpPWpGaD
Lithium—Discomfort—Gabapentin—migraine	0.00012	0.00133	CcSEcCtD
Lithium—Anorexia—Timolol—migraine	0.000119	0.00132	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—RAMP1—migraine	0.000119	0.00502	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CALCRL—migraine	0.000119	0.00502	CbGpPWpGaD
Lithium—Dry mouth—Gabapentin—migraine	0.000119	0.00131	CcSEcCtD
Lithium—Flatulence—Topiramate—migraine	0.000118	0.00131	CcSEcCtD
Lithium—Nausea—Verapamil—migraine	0.000118	0.0013	CcSEcCtD
Lithium—GSK3B—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000118	0.00497	CbGpPWpGaD
Lithium—Dysgeusia—Topiramate—migraine	0.000118	0.0013	CcSEcCtD
Lithium—Confusional state—Gabapentin—migraine	0.000117	0.0013	CcSEcCtD
Lithium—Hypotension—Timolol—migraine	0.000117	0.00129	CcSEcCtD
Lithium—Oedema—Gabapentin—migraine	0.000116	0.00129	CcSEcCtD
Lithium—Feeling abnormal—Valproic Acid—migraine	0.000116	0.00128	CcSEcCtD
Lithium—Gastrointestinal pain—Valproic Acid—migraine	0.000115	0.00127	CcSEcCtD
Lithium—Shock—Gabapentin—migraine	0.000115	0.00127	CcSEcCtD
Lithium—Musculoskeletal discomfort—Timolol—migraine	0.000114	0.00126	CcSEcCtD
Lithium—Vision blurred—Topiramate—migraine	0.000113	0.00125	CcSEcCtD
Lithium—Tremor—Topiramate—migraine	0.000112	0.00124	CcSEcCtD
Lithium—Somnolence—Timolol—migraine	0.000111	0.00123	CcSEcCtD
Lithium—Body temperature increased—Valproic Acid—migraine	0.000111	0.00123	CcSEcCtD
Lithium—Abdominal pain—Valproic Acid—migraine	0.000111	0.00123	CcSEcCtD
Lithium—Anorexia—Gabapentin—migraine	0.000111	0.00123	CcSEcCtD
Lithium—Agitation—Topiramate—migraine	0.00011	0.00122	CcSEcCtD
Lithium—Dyspepsia—Timolol—migraine	0.00011	0.00122	CcSEcCtD
Lithium—Hypotension—Gabapentin—migraine	0.000109	0.0012	CcSEcCtD
Lithium—Decreased appetite—Timolol—migraine	0.000109	0.0012	CcSEcCtD
Lithium—Vertigo—Topiramate—migraine	0.000108	0.00119	CcSEcCtD
Lithium—Fatigue—Timolol—migraine	0.000108	0.00119	CcSEcCtD
Lithium—Syncope—Topiramate—migraine	0.000108	0.00119	CcSEcCtD
Lithium—IMPA2—Metabolism—MTHFR—migraine	0.000106	0.00448	CbGpPWpGaD
Lithium—Musculoskeletal discomfort—Gabapentin—migraine	0.000106	0.00117	CcSEcCtD
Lithium—Loss of consciousness—Topiramate—migraine	0.000105	0.00117	CcSEcCtD
Lithium—Convulsion—Topiramate—migraine	0.000104	0.00115	CcSEcCtD
Lithium—GSK3A—Metabolism of proteins—ACE—migraine	0.000104	0.00438	CbGpPWpGaD
Lithium—Somnolence—Gabapentin—migraine	0.000103	0.00114	CcSEcCtD
Lithium—Feeling abnormal—Timolol—migraine	0.000103	0.00114	CcSEcCtD
Lithium—Dyspepsia—Gabapentin—migraine	0.000102	0.00113	CcSEcCtD
Lithium—Gastrointestinal pain—Timolol—migraine	0.000102	0.00113	CcSEcCtD
Lithium—Arthralgia—Topiramate—migraine	0.000102	0.00113	CcSEcCtD
Lithium—Decreased appetite—Gabapentin—migraine	0.000101	0.00112	CcSEcCtD
Lithium—Discomfort—Topiramate—migraine	0.000101	0.00112	CcSEcCtD
Lithium—GSK3A—Disease—LRP1—migraine	0.000101	0.00426	CbGpPWpGaD
Lithium—Asthenia—Valproic Acid—migraine	0.000101	0.00111	CcSEcCtD
Lithium—Fatigue—Gabapentin—migraine	0.0001	0.00111	CcSEcCtD
Lithium—Dry mouth—Topiramate—migraine	9.99e-05	0.0011	CcSEcCtD
Lithium—Abdominal pain—Timolol—migraine	9.88e-05	0.00109	CcSEcCtD
Lithium—Body temperature increased—Timolol—migraine	9.88e-05	0.00109	CcSEcCtD
Lithium—Confusional state—Topiramate—migraine	9.87e-05	0.00109	CcSEcCtD
Lithium—Oedema—Topiramate—migraine	9.79e-05	0.00108	CcSEcCtD
Lithium—Shock—Topiramate—migraine	9.63e-05	0.00107	CcSEcCtD
Lithium—Diarrhoea—Valproic Acid—migraine	9.61e-05	0.00106	CcSEcCtD
Lithium—Feeling abnormal—Gabapentin—migraine	9.59e-05	0.00106	CcSEcCtD
Lithium—Gastrointestinal pain—Gabapentin—migraine	9.52e-05	0.00105	CcSEcCtD
Lithium—IMPA1—Metabolism—MTHFR—migraine	9.46e-05	0.004	CbGpPWpGaD
Lithium—Anorexia—Topiramate—migraine	9.33e-05	0.00103	CcSEcCtD
Lithium—Dizziness—Valproic Acid—migraine	9.29e-05	0.00103	CcSEcCtD
Lithium—Abdominal pain—Gabapentin—migraine	9.2e-05	0.00102	CcSEcCtD
Lithium—Body temperature increased—Gabapentin—migraine	9.2e-05	0.00102	CcSEcCtD
Lithium—Hypotension—Topiramate—migraine	9.15e-05	0.00101	CcSEcCtD
Lithium—Asthenia—Timolol—migraine	8.97e-05	0.000992	CcSEcCtD
Lithium—Vomiting—Valproic Acid—migraine	8.93e-05	0.000987	CcSEcCtD
Lithium—Musculoskeletal discomfort—Topiramate—migraine	8.92e-05	0.000986	CcSEcCtD
Lithium—Rash—Valproic Acid—migraine	8.85e-05	0.000979	CcSEcCtD
Lithium—Dermatitis—Valproic Acid—migraine	8.85e-05	0.000978	CcSEcCtD
Lithium—Headache—Valproic Acid—migraine	8.8e-05	0.000973	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—RAMP1—migraine	8.78e-05	0.00371	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CALCRL—migraine	8.78e-05	0.00371	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—FOS—migraine	8.75e-05	0.0037	CbGpPWpGaD
Lithium—Somnolence—Topiramate—migraine	8.71e-05	0.000963	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—HTR1D—migraine	8.63e-05	0.00365	CbGpPWpGaD
Lithium—Dyspepsia—Topiramate—migraine	8.62e-05	0.000953	CcSEcCtD
Lithium—Diarrhoea—Timolol—migraine	8.55e-05	0.000946	CcSEcCtD
Lithium—Decreased appetite—Topiramate—migraine	8.51e-05	0.000941	CcSEcCtD
Lithium—Fatigue—Topiramate—migraine	8.44e-05	0.000933	CcSEcCtD
Lithium—Asthenia—Gabapentin—migraine	8.35e-05	0.000923	CcSEcCtD
Lithium—Nausea—Valproic Acid—migraine	8.34e-05	0.000922	CcSEcCtD
Lithium—Dizziness—Timolol—migraine	8.27e-05	0.000914	CcSEcCtD
Lithium—GSK3A—Integrated Pancreatic Cancer Pathway—TNF—migraine	8.25e-05	0.00348	CbGpPWpGaD
Lithium—Feeling abnormal—Topiramate—migraine	8.07e-05	0.000892	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—HTR2B—migraine	8.02e-05	0.00339	CbGpPWpGaD
Lithium—Gastrointestinal pain—Topiramate—migraine	8.01e-05	0.000885	CcSEcCtD
Lithium—Diarrhoea—Gabapentin—migraine	7.96e-05	0.000881	CcSEcCtD
Lithium—Vomiting—Timolol—migraine	7.95e-05	0.000879	CcSEcCtD
Lithium—Rash—Timolol—migraine	7.88e-05	0.000871	CcSEcCtD
Lithium—Dermatitis—Timolol—migraine	7.87e-05	0.000871	CcSEcCtD
Lithium—Headache—Timolol—migraine	7.83e-05	0.000866	CcSEcCtD
Lithium—Body temperature increased—Topiramate—migraine	7.74e-05	0.000856	CcSEcCtD
Lithium—Abdominal pain—Topiramate—migraine	7.74e-05	0.000856	CcSEcCtD
Lithium—Dizziness—Gabapentin—migraine	7.7e-05	0.000851	CcSEcCtD
Lithium—GSK3B—Disease—LRP1—migraine	7.45e-05	0.00315	CbGpPWpGaD
Lithium—Nausea—Timolol—migraine	7.42e-05	0.000821	CcSEcCtD
Lithium—Vomiting—Gabapentin—migraine	7.4e-05	0.000818	CcSEcCtD
Lithium—Rash—Gabapentin—migraine	7.34e-05	0.000811	CcSEcCtD
Lithium—Dermatitis—Gabapentin—migraine	7.33e-05	0.000811	CcSEcCtD
Lithium—Headache—Gabapentin—migraine	7.29e-05	0.000806	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—LRP1—migraine	7.06e-05	0.00298	CbGpPWpGaD
Lithium—Asthenia—Topiramate—migraine	7.03e-05	0.000777	CcSEcCtD
Lithium—Nausea—Gabapentin—migraine	6.91e-05	0.000764	CcSEcCtD
Lithium—Diarrhoea—Topiramate—migraine	6.7e-05	0.000741	CcSEcCtD
Lithium—GSK3A—Disease—CALCA—migraine	6.5e-05	0.00275	CbGpPWpGaD
Lithium—Dizziness—Topiramate—migraine	6.48e-05	0.000716	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—HTR1D—migraine	6.38e-05	0.00269	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—FOS—migraine	6.33e-05	0.00268	CbGpPWpGaD
Lithium—Vomiting—Topiramate—migraine	6.23e-05	0.000688	CcSEcCtD
Lithium—Rash—Topiramate—migraine	6.17e-05	0.000683	CcSEcCtD
Lithium—Dermatitis—Topiramate—migraine	6.17e-05	0.000682	CcSEcCtD
Lithium—Headache—Topiramate—migraine	6.13e-05	0.000678	CcSEcCtD
Lithium—GSK3B—Signaling Pathways—HTR2B—migraine	5.93e-05	0.00251	CbGpPWpGaD
Lithium—Nausea—Topiramate—migraine	5.82e-05	0.000643	CcSEcCtD
Lithium—GSK3A—Signaling Pathways—NOTCH4—migraine	5.42e-05	0.00229	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFBR2—migraine	5.24e-05	0.00221	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR1B—migraine	5.23e-05	0.00221	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LRP1—migraine	5.22e-05	0.00221	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR1A—migraine	5.03e-05	0.00213	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PGR—migraine	4.96e-05	0.00209	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TAC1—migraine	4.96e-05	0.00209	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NPS—migraine	4.96e-05	0.00209	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2C—migraine	4.86e-05	0.00205	CbGpPWpGaD
Lithium—GSK3B—Disease—CALCA—migraine	4.8e-05	0.00203	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EDNRA—migraine	4.73e-05	0.002	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—FOS—migraine	4.68e-05	0.00198	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOTCH3—migraine	4.61e-05	0.00195	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CALCA—migraine	4.55e-05	0.00192	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR7—migraine	4.26e-05	0.0018	CbGpPWpGaD
Lithium—GSK3A—Disease—MTHFR—migraine	4.25e-05	0.0018	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOTCH4—migraine	4e-05	0.00169	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFBR2—migraine	3.87e-05	0.00163	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR1B—migraine	3.86e-05	0.00163	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR1A—migraine	3.72e-05	0.00157	CbGpPWpGaD
Lithium—GSK3A—Immune System—FOS—migraine	3.69e-05	0.00156	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFBR2—migraine	3.67e-05	0.00155	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TAC1—migraine	3.66e-05	0.00155	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PGR—migraine	3.66e-05	0.00155	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NPS—migraine	3.66e-05	0.00155	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2C—migraine	3.59e-05	0.00152	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EDNRA—migraine	3.49e-05	0.00148	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOTCH3—migraine	3.41e-05	0.00144	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CALCA—migraine	3.36e-05	0.00142	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR7—migraine	3.15e-05	0.00133	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—migraine	3.14e-05	0.00133	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—migraine	2.98e-05	0.00126	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—migraine	2.85e-05	0.0012	CbGpPWpGaD
Lithium—GSK3B—Immune System—FOS—migraine	2.73e-05	0.00115	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFBR2—migraine	2.71e-05	0.00114	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ESR1—migraine	2.65e-05	0.00112	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—migraine	2.2e-05	0.000931	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ESR1—migraine	1.96e-05	0.000826	CbGpPWpGaD
